Yin-Cheng
Yin-Cheng Chang, Hsinchu TW
Patent application number | Description | Published |
---|---|---|
20140292364 | SEMICONDUCTOR CHIP PROBE AND THE CONDUCTED EME MEASUREMENT APPARATUS WITH THE SEMICONDUCTOR CHIP PROBE - The present invention discloses a semiconductor chip probe for measuring conducted electromagnetic emission (EME) of a bare die and a conducted EME measurement apparatus with the semiconductor chip probe. The semiconductor chip probe comprises a substrate, a dielectric layer, an impedance unit, a measuring unit and a connection unit. The measurement apparatus comprises a semiconductor chip probe, a high frequency probe, a signal cable and a test receiver. The integrated passive component network designed and embedded inside the semiconductor chip probe forms the 1Ω or 150Ω impedance network. And the semiconductor chip probe is able to directly couple the EME conducted current or voltage from the test pin of the flipped chip under test to the test receiver for measurement. | 10-02-2014 |
Yin-Cheng Chang, Hsinchu City TW
Patent application number | Description | Published |
---|---|---|
20150268272 | CONDUCTED TYPE CURRENT PROBE - A conducted type current probe is provided herein and comprises a plurality of first resistors, at least one second resistor, a first connective port, and a second connective port. The first resistors are connected in parallel to form a resistor with 1Ω resistance value, and the resistance value of the second resistor is 49Ω. The first resistors and the second resistor are connected. The first connective port is connected with a test end of a test Integrated Circuit (IC), and the second connective port is connected with a test receiver by a coaxial cable. | 09-24-2015 |
Yin-Cheng Huang, Hsinchu TW
Patent application number | Description | Published |
---|---|---|
20110306668 | CONSTRUCTION AND SCREENING OF SOLUTION-PHASE DERIVED LIBRARY OF FENBUFEN AND ETHACRYNIC ACID - A process for synthesizing and screening solution phase derived libraries of fenbufen and ethacrynic acid is provided in the present invention. Compounds in the present invention having cytotoxicities are useful for a variety of therapeutic applications. | 12-15-2011 |
20130156701 | METHOD OF PREPARING ETHACRYNIC AMIDE DERIVATIVES AND APPLICATION THEREOF - The present invention provides a method for preparing [ | 06-20-2013 |
Yin-Cheng Huang, New Taipei City TW
Patent application number | Description | Published |
---|---|---|
20130217639 | COMPOUND FOR ACTIVATING NATURAL KILLER T CELLS AND PREPARING METHOD THEREOF - The present invention provides a compound selected from compound of formula (I), pharmaceutically acceptable salts of compound of formula (I), and pharmaceutically acceptable prodrugs of compound of formula (I), | 08-22-2013 |
Yin-Cheng Lin, Hsin-Chu TW
Patent application number | Description | Published |
---|---|---|
20140118991 | WAVELENGTH CONVERSION WHEEL MODULE AND ILLUMINATION SYSTEM - A wavelength conversion wheel module and an illumination system are provided. The wavelength conversion wheel module includes a wavelength conversion wheel and a first actuator. The wavelength conversion wheel includes a plurality of annular areas. Each of the annular areas includes at least one wavelength conversion area and at least one light passing area. The wavelength conversion area converts an original light beam incident on the wavelength conversion area into a converted light beam. The wavelength of the converted light beam is different from the wavelength of the original light beam. The annular areas are arranged along the radial direction of the wavelength conversion wheel, and different annular areas have different optical parameters. The optical parameters of the annular areas are related to the wavelength conversion area and the light passing area. The first actuator is connected to the wavelength conversion wheel, and drives the wavelength conversion wheel to rotate. | 05-01-2014 |
Yin-Cheng Lo, Green Oaks, IL US
Patent application number | Description | Published |
---|---|---|
20140042092 | THERAPY PREDICTION AND OPTIMIZATION OF SERUM POTASSIUM FOR RENAL FAILURE BLOOD THERAPY, ESPECIALLY HOME HEMODIALYSIS - A method of predicting serum potassium concentrations in a patient during hemodialysis includes measuring serum potassium concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a potassium mobilization clearance and a pre-dialysis distribution volume of potassium for the patient. Serum potassium concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated potassium mobilization clearance and pre-dialysis distribution volume of potassium of the patient. | 02-13-2014 |